Bausch + Lomb Corp., a global leader in eye health, has announced the pricing of an upsized senior secured notes offering by its subsidiaries, Bausch+Lomb Netherlands B.V. and Bausch & Lomb Incorporated. The offering comprises €675 million in aggregate principal amount of senior secured floating rate notes due in 2031, increased from the previously announced €600 million. The notes are being sold to investors at 99.500% of the principal amount and are expected to close on June 26, 2025, subject to customary conditions. Additionally, the company is pursuing a partial refinancing of its credit agreement, aiming to secure a $2.325 billion new term B loan facility and an $800 million revolving credit facility. The proceeds from the notes offering and the new loan facility will be used to repay existing borrowings and refinance outstanding loans. The notes are offered under Rule 144A and Regulation S of the Securities Act.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.